Viramune, Retardtabletten
7680620770014
CH-62077
Tabletten
Associated product:
Viramune, Retardtabletten
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nevirapinum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
400.0 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
Authorization holder
Boehringer Ingelheim (Schweiz) GmbH
4057 Basel
Authorization information
- Swissmedic authorization number
- 62077
- Drug name
- Viramune, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/01/2012
- Authorization expiration date
- 31/08/2026
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- VIRAMUNE cpr ret 400 mg 30 pce
- Description (DE)
- VIRAMUNE Ret Tabl 400 mg 30 Stk
- Market launch
- 10/01/2012
- Market withdrawal
- 31/08/2026
- Narcotic (BTM)
- No